EUVIMEDEUVIMED entdecken
Open Access

Attitudes in Patients With Prodromal and Overt α ‐Synucleinopathy Toward Risk Disclosure: A Nationwide Registry

Rezzak Yilmaz iD, Gülce Coşku Yılmaz Çakan iD, Yeşim Sücüllü Karadağ, Ülkü Dübüş Hoş, Ahmet Acarer, Vasfiye Kabeloğlu, Rıza Sonkaya, Gençer Genç, Aysegul Gunduz, Bilge Koçer, Hikmet Yılmaz, Sevda Erer und 38 weitere

Movement Disorders Clinical Practice · 2026

DOI: 10.1002/mdc3.70745 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2026. Verfasst von Rezzak Yilmaz und 49 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Ankara University School of Medicine, Ankara, Türkiye. Hauptthemen laut MEDLINE: Registries, Parkinson Disease, Multiple System Atrophy, Synucleinopathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Identification of individuals at increased risk for synucleinopathies is becoming more feasible with advances in biomarkers. However, the ethical and practical aspects of communicating disease risk remain unresolved, particularly across diagnostic groups and cultural contexts.

Objectives

We aimed to evaluate attitudes toward disclosure of future synucleinopathy risk among individuals with isolated/idiopathic REM sleep behavior disorder (iRBD), as well as in individuals who developed Parkinson's disease (PD), or multiple system atrophy (MSA), in a large non‐Western registry.

Methods

This nationwide survey study included participants from 28 movement disorders and sleep centers across Türkiye. Questionnaires assessing attitudes toward risk disclosure, additional testing, and clinical trial participation were administered face‐to‐face. Responses were analyzed using contingency tables and regression models. Results are reported following the Consensus‐Based Checklist for Reporting of Survey Studies (CROSS) guideline.

Results

Among 1385 participants (1039 PD, 107 MSA, 239 iRBD), individuals with iRBD showed the highest support for risk disclosure (88.3%), exceeding PD (64.4%) and MSA (51.9%). Approval declined modestly (3–8%) when framed within the absence of disease‐modifying treatment. iRBD participants were more willing for additional testing but less willing to join clinical trials (31.8%) than PD (45.3%) or MSA (48%). MSA patients expressed the greatest concern about psychological impact. Male sex had more favorable views on disclosure and trial participation, while younger and better‐educated participants favored additional testing.

Conclusions

Attitudes toward risk disclosure differ markedly across the synucleinopathy spectrum and demographic characteristics. Culturally informed and diagnosis‐specific disclosure strategies will be essential for trial recruitment and patient‐centered care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RegistriesParkinson DiseaseMultiple System AtrophySynucleinopathiesProdromal SymptomsREM Sleep Behavior DisorderDisclosureHumansMaleFemaleMiddle AgedAgedSurveys and QuestionnairesAdult

Stichwörter der Autor:innen

Parkinson's diseaseiRBDmultiple system atrophyprodromalrisk disclosure

Autor:innen und Institutionen

  • Department of Neurology, Ankara University School of Medicine, Ankara, Türkiye.
  • Istanbul Faculty of Medicine, Department of Neurology, Behavioral Neurology and Movement Disorders Unit, Istanbul University, Istanbul, Türkiye.
  • Department of Neurology, University of Health Sciences, Ankara Bilkent City Hospital, Ankara, Türkiye.
  • Department of Neurology, University of Health Sciences, Başakşehir Çam and Sakura City Hospital, Istanbul, Türkiye.
  • Department of Neurology, Ege University School of Medicine, Izmir, Türkiye.
  • Department of Neurology, Bakırköy Mazhar Osman Educational and Research Hospital, University of Health Sciences, Istanbul, Türkiye.

ORCID-Profile: Rezzak Yilmaz, Gülce Coşku Yılmaz Çakan, Murat Gultekin, Bedia Samanci, Rümeysa Unkun Altun, Gizem Güllü, Gül Yalçın Çakmaklı, Ayşenur Şahin, M Cenk Akbostancı

Zitieren

APA

Yilmaz, R., Çakan, G. C. Y., Karadağ, Y. S., Hoş, Ü. D., Acarer, A., Kabeloğlu, V., Sonkaya, R., Genç, G., Gunduz, A., Koçer, B., Yılmaz, H., Erer, S., Gultekin, M., Tokçaer, A. B., Ataoğlu, E. E., Samanci, B., Gençler, O. S., Tuncel, R., Şahin, E., …, & Şenel, G. B. (2026). Attitudes in Patients With Prodromal and Overt α ‐Synucleinopathy Toward Risk Disclosure: A Nationwide Registry. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.70745

Vancouver

Yilmaz R, Çakan GCY, Karadağ YS, Hoş ÜD, Acarer A, Kabeloğlu V, et al. Attitudes in Patients With Prodromal and Overt α ‐Synucleinopathy Toward Risk Disclosure: A Nationwide Registry. Movement Disorders Clinical Practice. 2026. doi:10.1002/mdc3.70745

BibTeX
@article{Yilmaz2026,
  author = {Yilmaz, Rezzak and Çakan, Gülce Coşku Yılmaz and Karadağ, Yeşim Sücüllü and Hoş, Ülkü Dübüş and Acarer, Ahmet and Kabeloğlu, Vasfiye and Sonkaya, Rıza and Genç, Gençer and Gunduz, Aysegul and Koçer, Bilge and Yılmaz, Hikmet and Erer, Sevda and Gultekin, Murat and Tokçaer, Ayşe Bora and Ataoğlu, Esra Erkoç and Samanci, Bedia and Gençler, Onur Serdar and Tuncel, Rasim and Şahin, Erdi and Pak, Tina and Demirelli, Derya Selçuk and İbiş, Selen Yılmaz and Çöklü, Hilal and Baydemir, Recep and Altun, Rümeysa Unkun and Güllü, Gizem and Çiftçi, Ömer Faruk and Metin, Kübra Mehel and Demiryürek, Bekir Enes and Çakmaklı, Gül Yalçın and Bilgiç, Başar and Dogu, Okan and Özer, Feriha and Aksu, Murat and Berktas, Deniz Tuncel and Akyildiz, Utku Ogan and Karadeniz, Derya and Çokal, Burcu Gökçe and Demir, Aylin Bican and Gençdal, Işıl Yazıcı and Saritas, Aysegul Seyma and Ak, Aysin Kısabay and Şahin, Ayşenur and Aslan-Kara, Kezban and Ismailogullari, Sevda and Tezer, F Irsel and Hanağası, Haşmet and Akbostancı, M Cenk and St Louis, Erik K and Şenel, Gülçin Benbir},
  title = {Attitudes in Patients With Prodromal and Overt α ‐Synucleinopathy Toward Risk Disclosure: A Nationwide Registry},
  journal = {Movement Disorders Clinical Practice},
  year = {2026},
  doi = {10.1002/mdc3.70745}
}
Kostenlos starten →